SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
Active, not recruiting · NCT04977024 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer | Blood Protein Disorders, COVID-19, Coronaviridae Infections, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, cardiovascular disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lung disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, vascular disorder, vascular hemostatic disease, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-02-11 | NCT04977024 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GeoVax, Inc. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Wake Forest Baptist | Winston-Salem | United States | 52 |
| City of Hope Medical Center | Duarte | United States | 313 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Johns Hopkins University | Baltimore | United States | 60 |
| SUNY-Stony Brook | Stony Brook | United States | 1 |
| U Mass Chan Medical School | Worcester | United States | 1 |